+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
JAGSNPHARM

Jagsonpal Pharmaceuticals Share Price

₹213.21 -6.68 (-3.04%)
37.55% Gain from 52W Low

06 Nov, 2026 3:51 PM (IST)

Jagsonpal Pharmaceuticals live price: ₹213.21. It opened at ₹222 vs previous close ₹220; intraday high/low: ₹222/₹210. The 50 & 200 DMA stand at ₹225.10/₹218.60.

Jagsonpal Pharmaceuticals Performance

  • Today's Low
  • ₹210
  • Today's High
  • ₹222
  • 52 Week Low
  • ₹155
  • 52 Week High
  • ₹265
  • Open Price₹222
  • Previous Close₹220
  • Volume96,648
  • 50 DMA₹225.10
  • 100 DMA₹223.70
  • 200 DMA₹218.60

Jagsonpal Pharmaceuticals Chart

Investment Returns

  • Over 1 Month -8.74%
  • Over 3 Month -10.43%
  • Over 6 Month + 1.5%
  • Over 1 Year -1.59%

Smart Investing Starts Here Start SIP with Jagsonpal Pharmaceuticals for Steady Growth!

Invest Now

Jagsonpal Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 30.9
  • PEG Ratio
  • -1.2
  • Market Cap Cr
  • 1,406
  • P/B Ratio
  • 4.9
  • Average True Range
  • 9.8
  • EPS
  • 6.9
  • Dividend Yield
  • 1.9
  • MACD Signal
  • -3.2
  • RSI
  • 40.54
  • MFI
  • 31.37

Latest Stock News Updates

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Earning call transcript for Jagsonpal Pharmaceuticals Limited Q2 FY 27 Earning Conference Call on October 29, 2026 at 2:00 P.M

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Audio Recording of Jagsonpal Pharmaceuticals Limited Q2 FY27 Earnings Conference call on October 29, 2026 at 02:00 P.M.

Jagsonpal Pharmaceuticals Ltd - 507789 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication providing extracts of Unaudited Results of Company for the quarter and half ended September 30, 2026.

Jagsonpal Pharmaceuticals Financials

Jagsonpal Pharmaceuticals Technicals

EMA & SMA

Current Price
₹213.21
-6.68 (-3.04%)
pointer
  • Bearish Moving Average 15
  • Bullish Moving Average 1
  • 20 Day
  • ₹221.00
  • 50 Day
  • ₹225.10
  • 100 Day
  • ₹223.70
  • 200 Day
  • ₹218.60

Resistance and Support

214.87 Pivot Speed
  • R3 231.80
  • R2 226.70
  • R1 220.00
  • S1 208.10
  • S2 203.00
  • S3 196.30

Jagsonpal Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-28 Quarterly Results
2026-07-29 Quarterly Results
2026-04-27 Audited Results & Final Dividend
2026-03-12 Buy Back of Shares
2026-01-21 Quarterly Results
Date Purpose Remarks
2026-09-04 FINAL Rs.4.00 per share(200%)Final Dividend
2025-09-12 FINAL Rs.2.50 per share(125%)Final Dividend
2024-09-06 FINAL Rs.5.00 per share(100%)Final Dividend
2023-08-21 FINAL Rs.5.00 per share(100%)Dividend
2021-11-01 INTERIM Rs.4.00 per share(80%)Interim Dividend
View Jagsonpal Pharmaceuticals Dividend History Arrow
Date Purpose Remarks
2025-01-08 Split Stock split from Rs. 5/- to Rs. 2/-.
2004-07-28 Split Subdivision of equity shares from Rs. 10/- to Rs. 5/-

Jagsonpal Pharmaceuticals Shareholding Pattern

68.81%
27.4%
2.13%
1.64%

About Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals is engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients. View More
  • NSE Symbol
  • JAGSNPHARM
  • BSE Symbol
  • 507789
  • ISIN
  • INE048B01035

Similar Stocks to Jagsonpal Pharmaceuticals

Jagsonpal Pharmaceuticals FAQs

Jagsonpal Pharmaceuticals share price is ₹213 As on 07 November, 2026 | 19:21

The Market Cap of Jagsonpal Pharmaceuticals is ₹1406.3 Cr As on 07 November, 2026 | 19:21

The P/E ratio of Jagsonpal Pharmaceuticals is 30.9 As on 07 November, 2026 | 19:21

The PB ratio of Jagsonpal Pharmaceuticals is 4.9 As on 07 November, 2026 | 19:21

The 52 week High & Low of Jagsonpal Pharmaceuticals is ₹264.5/₹155 respectively As on 07 November, 2026 | 19:21

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23